for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Amicus Therapeutics Q3 loss per share $0.69

Nov 8 (Reuters) - Amicus Therapeutics Inc:

* Amicus therapeutics announces third quarter 2017 financial results and corporate updates

* Q3 loss per share $0.69

* Q3 revenue $10.9 million versus I/B/E/S view $9.5 million

* Q3 adjusted loss per share $0.41 excluding items

* Q3 earnings per share view $-0.31 -- Thomson Reuters I/B/E/S

* Amicus Therapeutics Inc - reiterated full-year 2017 financial guidance

* Amicus Therapeutics Inc - current cash position anticipated to fund ongoing operations into at least H2 2019 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up